Utility of Rivaroxaban for Real-World Patients With Venous Thromboembolism

被引：0
|
作者：
Yamashita, Yugo [1 ]
机构：
[1] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, 54 Shogoin Kawahara Cho, Sakyo Ku, Kyoto 6068507, Japan
来源：
CIRCULATION JOURNAL | 2023年 / 87卷 / 09期
关键词：
ORAL RIVAROXABAN;
D O I：
10.1253/circj.CJ-23-0291
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1185 / 1186
页数：2
相关论文
共 50 条
  • [1] Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban: An Analysis of Real-World Data
    Dawwas, Ghadeer K.
    Leonard, Charles E.
    Lewis, James D.
    Cuker, Adam
    [J]. ANNALS OF INTERNAL MEDICINE, 2022, 175 (01) : 20 - +
  • [2] Risk of recurrent venous thromboembolism and bleeding with apixaban versus rivaroxaban: an analysis of real-world data
    Villoing, B.
    [J]. ANNALES FRANCAISES DE MEDECINE D URGENCE, 2022, 12 (02): : 131 - 131
  • [3] Efficacy and Safety of Rivaroxaban for Extremely Aged Patients with Venous Thromboembolism: A Retrospective, Cross-Sectional Real-World Study
    Wang, Chun
    Fan, Xiaohong
    Nie, Li
    Wang, Qing
    Li, Shanshan
    Zheng, Wen
    Zhang, Wei
    Dai, Wangshu
    Chen, Minmin
    [J]. CLINICAL INTERVENTIONS IN AGING, 2024, 19 : 1103 - 1116
  • [4] Duration of risk of venous thromboembolism in real-world US surgical patients
    Amin, Alpesh N.
    Lenhart, Greg
    Lin, Jay
    Thompson, Stephen
    Johnston, Stephen
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 31 (03) : 398 - 399
  • [5] Real world experience of efficacy and safety of rivaroxaban in paediatric venous thromboembolism
    Hassan, Eman
    Motwani, Jayashree
    [J]. THROMBOSIS RESEARCH, 2023, 221 : 92 - 96
  • [6] The comparative effectiveness and safety of warfarin, rivaroxaban, and apixaban in patients with venous thromboembolism: An analysis of three real-world US healthcare databases
    Iyer, Geetha
    Tesfaye, Helen
    Brill, Gregory
    Zakoul, Heidi
    Schneeweiss, Sebastian
    Bykov, Katsiaryna
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 11 - 12
  • [7] Factors Associated with Bleeding Events in Patients Receiving Rivaroxaban for Venous Thromboembolism: A Real World Experience
    Mangla, Ankit
    Mushtaq, Muhammad Umair
    Paydary, Koosha
    Mann, Hashim
    Liu, Jiaxiang
    Krishnan, Jayasree
    Akhtar, Tauseef
    Mattumpuram, Jishanth
    Putta, Aakash
    Uprety, Alok
    Wang, Yanting
    Yim, Barbra
    Lad, Thomas
    [J]. BLOOD, 2018, 132
  • [8] Population Pharmacokinetics of Rivaroxaban in Real-World Patients
    Alqahtani, Saeed
    Alnahdi, Jamilah
    Almofada, Razan
    bin Hazza, Asma'a
    Alsultan, Abdullah
    Alqahtani, Farjah
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (08): : 943 - 949
  • [9] UK real-world experience of prescribing rivaroxaban for acute venous thromboembolism in obesity: Results from the FIRST Registry
    Speed, V.
    Patel, J. P.
    Roberts, L. N.
    Patel, R. K.
    Arya, R.
    [J]. THROMBOSIS RESEARCH, 2021, 197 : 16 - 19
  • [10] Venous Thromboembolism in Patients With Myeloma: Incidence and Risk Factors in a "Real-World" Population
    Crowley, Maeve P.
    Eustace, Joseph A.
    O'Shea, Susan I.
    Gilligan, Oonagh M.
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2014, 20 (06) : 600 - 606
12345